日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modulating the Binding Kinetics of Bruton's Tyrosine Kinase Inhibitors through Transition-State Effects

通过过渡态效应调节布鲁顿酪氨酸激酶抑制剂的结合动力学

Bravo, Eduardo Jr; Li, Yong; Lin, David Yin-Wei; Srinivasan, Bharath; Barone, Marco; Li, Stan Xiaogang; DelloRusso, Francesca; Rahiyanath, Anza Suneer; Corrionero, Ana; Alfonso, Patricia; Prendiville, Niall; Kozakov, Dima; Andreotti, Amy H; Tonge, Peter J

Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 Inhibitor.

RIPK1 选择性苯并[1,4]氧氮杂环庚酮-4-酮骨架的再利用,用于开发 III 型 LIMK1/2 抑制剂

Mandel Sebastian, Hanke Thomas, Mathea Sebastian, Chatterjee Deep, Saraswati Hayuningbudi, Berger Benedict-Tilman, Schwalm Martin Peter, Yamamoto Satoshi, Tawada Michiko, Takagi Terufumi, Ahmed Mahmood, Röhm Sandra, Corrionero Ana, Alfonso Patricia, Baena Maria, Elson Lewis, Menge Amelie, Krämer Andreas, Pereira Raquel, Müller Susanne, Krause Daniela S, Knapp Stefan

An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors

对几种布鲁顿酪氨酸激酶(BTK)抑制剂的激酶选择性、酶抑制动力学和体外活性进行评估

Corrionero, Ana; Zhang, Xiaohu; Alfonso, Patricia; Morris, Patrick J; Klumpp-Thomas, Carleen; Melani, Christopher; McKnight, Crystal; Phelan, James D; Holland, David; Wilson, Kelli; Hoyt, Scott B; Roschewski, Mark; Tonge, Peter J; Wilson, Wyndham; Ceribelli, Michele; Staudt, Louis M; Thomas, Craig J

Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia

联合CRISPR和转座子技术优化通用同种异体CAR-T细胞治疗急性髓系白血病

Cristina Calviño, Candela Ceballos, Ana Alfonso, Patricia Jauregui, Maria E Calleja-Cervantes, Patxi San Martin-Uriz, Paula Rodriguez-Marquez, Angel Martin-Mallo, Elena Iglesias, Gloria Abizanda, Saray Rodriguez-Diaz, Rebeca Martinez-Turrillas, Jorge Illarramendi, Maria C Viguria, Margarita Redondo,